Aquamin study probes gut barrier changes in digestive disorders
NCT ID NCT04855799
First seen Jun 14, 2026 · Last updated Jun 16, 2026 · Updated 1 time
Summary
This completed Phase 2 trial tested whether Aquamin, a mineral supplement, changes how leaky the gut is in people with ulcerative colitis, irritable bowel syndrome with diarrhea, and healthy individuals. 35 participants took Aquamin for 90 days, and researchers measured gut permeability using urine tests. The goal was to understand how Aquamin might affect the gut barrier, not to treat or cure any condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of Michigan Hospital
Ann Arbor, Michigan, 48109, United States
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.